Properties of leukokininogen isolated from human neoplastic ascites
- 1 April 1979
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 28 (7) , 1043-1050
- https://doi.org/10.1016/0006-2952(79)90301-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Pepstatin, an Ascites Retardant of L1210 Tumor-Bearing Mice: Brief Communication2JNCI Journal of the National Cancer Institute, 1977
- Protease activity of normal and PHA stimulated human lymphocytesCellular Immunology, 1975
- The use of Coomassie Brilliant Blue G250 perchloric acid solution for staining in electrophoresis and isoelectric focusing on polyacrylamide gelsAnalytical Biochemistry, 1975
- The leukokinin system; Its role in fluid accumulation in malignancy and inflammationInflammation Research, 1973
- Studies on leukokinins—III: Pharmacological activities of leukokinins M and PMNBiochemical Pharmacology, 1972
- Glass-activated plasma kallikreinBiochemical Pharmacology, 1970
- Sensitive proteolytic enzyme assay using differential solubilities of radioactive substrates and products in biphasic systemsAnalytical Biochemistry, 1970
- PMN‐kinin and kinin metabolizing enzymes in normal and malignant leucocytesBritish Journal of Pharmacology, 1969
- DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS*Annals of the New York Academy of Sciences, 1964
- Studies on the isolation of BradykininogenBiochemical Pharmacology, 1963